Calcium and bone health: Position statement for the Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia and the Endocrine Society of Australia

Medical Journal of Australia

Volumn 190, Issue 6, 2009, Pages 316-320

  Sanders, Kerrie M ^a   Nowson, Caryl A ^b   Kotowicz, Mark A ^a   Briffa, Kathryn ^c   Devine, Amanda ^d   Reid, Ian R ^e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c CURTIN UNIVERSITY   (Australia)

^d EDITH COWAN UNIVERSITY   (Australia)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; PLACEBO; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

ARTICLE; AUSTRALIA; BLOATING; BONE DENSITY; BONE DEVELOPMENT; BONE METABOLISM; BONE REMODELING; CALCIUM ABSORPTION; CLINICAL TRIAL; CONSTIPATION; DAIRY PRODUCT; DIET SUPPLEMENTATION; DRUG TOLERABILITY; FLATULENCE; FOOD COMPOSITION; FRAGILITY FRACTURE; HUMAN; LACTATION; MEDICAL SOCIETY; MENOPAUSE; NEW ZEALAND; NUTRITIONAL REQUIREMENT; OSTEOPOROSIS; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PREGNANCY; RECOMMENDED DRUG DOSE; RISK REDUCTION; WEIGHT BEARING;

EID: 63249116824     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02421.x     Document Type: Article

References (54)

1. National Health and Medical Research Council. How to use the evidence: assessment and application of scientific evidence. Canberra: NHMRC, 2000: 8 (Table 1.3). http://www.nhmrc.gov.au/publications/ synopses/_files/cp69.pdf (accessed Feb 2009).
2. Prince R, Devine A, Dhaliwal S, Dick I. Effects of calcium supplementation on clinical fracture and bone structure. Arch Intern Med 2006; 166: 869-875.
3. Tang B, Eslick G, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007; 370: 657-666.
4. Pettifor M. Privational rickets: a modern perspective. J R Soc Med 1994; 87: 723-725.
5. Abrams S, Copeland K, Gunn S, et al. Calcium absorption, bone mass accumulation, and kinetics increase during early pubertal development in girls. J Clin Endocrinol Metab 2000; 85: 1805-1809.
6. Lanou A, Berkow S, Barnard N. Calcium, dairy products and bone health in children and young adults: a reevaluation of the evidence. Pediatrics 2005; 115: 736-743.
7. Du X, Greenfield H, Fraser D, et al. Milk consumption and bone mineral content in Chinese adolescent girls. Bone 2002; 30: 521-528.
8. Bonjour J-P, Carrie A-L, Ferrari S, et al. Calcium-enriched foods and bone mass growth in prepubertal girls: a randomised, double-blind placebo-controlled trial. J Clin Invest 1997; 99: 1287-1294.
9. Johnston C, Miller J, Slemenda C, et al. Calcium supplementation and increases in bone mineral density in children. N Engl J Med 1992; 327: 82-87.
10. Nowson C, Green R, Hopper J, et al. A co-twin study of the effect of calcium supplementation on bone density during adolescence. Osteoporos Int 1997; 7: 219-225.
11. Winzenberg T, Shaw K, Fryer J, Jones G. Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials. BMJ 2006; 333: 775.
12. Matkovic V, Fontana D, Tominac C, et al. Factors that influence peak bone mass formation: a study of calcium balance and the inheritance of bone in adolescent females. Am J Clin Nutr 1990; 52: 878-888.
13. Bailey DA, Martin AD, McKay HA, et al. Calcium accretion in girls and boys during puberty: a longitudinal analysis. J Bone Miner Res 2000; 15: 2245-2250.
14. Barr D, Petit M, Vigna Y, Prior J. Eating attitudes and habitual calcium intake in peripubertal girls are associated with initial bone mineral content and its change over two years. J Bone Miner Res 2001; 16: 940-947.
15. Lloyd T, Petit M, Lin H, Beck T. Lifestyle factors and the development of bone mass and bone strength in young women. J Pediatr 2004; 144: 776-782.
16. Goulding A, Cannan R, Williams S, et al. Bone mineral density in girls with forearm fractures. J Bone Miner Res 1998; 13: 143-148.
17. National Health and Medical Research Council. Nutrient reference values for Australia and New Zealand. http://www.nrv.gov.au (accessed Feb 2009).
18. Prentice A. Maternal calcium metabolism and bone mineral status. Am J Clin Nutr 2000; 71 (5 Suppl): 1312S-1316S.
19. Bezerra F, Laboissiere F, King J, Donangelo C. Pregnancy and lactation affect markers of calcium and bone metabolism differently in adolescent and adult women with low calcium intakes. J Nutr 2002; 132: 2183-2187.
20. Michaelsson K, Baron J, Farahmand B, Ljunghall S. Influence of parity and lactation on hip fracture risk. Am J Epidemiol 2001; 153: 1166-1172.
21. Ortega R, Martinez R, Quintas M, et al. Calcium levels in maternal milk: relationships with calcium intake during the third trimester of pregnancy. Br J Nutr 1998; 79: 501-507.
22. Koo W, Walters J, Esterlitz J, et al. Maternal calcium supplementation and fetal bone mineralization. Obstet Gynecol 1999; 94: 577-582.
23. Nordin B. Calcium and osteoporosis. Nutrition 1997; 13: 664-686.
24. Shea B, Wells G, Cranny A, et al. Meta-anaiysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 2002; 23: 552-559.
25. Winters-Stone KM, Snow CM. One year of oral calcium supplementation maintains cortical bone density in young adult female distance runners. Int J Sport Nutr Exerc Metab 2004; 14: 7-17.
26. Cleghorn DB, O'Loughlin PD, Schroeder BJ, Nordin BE. An open, cross-over trial of calcium-fortified milk in prevention of early postmenopausal bone loss. Med J Aust 2001; 175: 242-245.
27. 3-fortified milk reduces bone loss at clinically relevant skeletal sites in older men: a 2-year randomised controlled trial. J Bone Miner Res 2006; 21: 397-405.
28. Dawson-Hughes B, Dallal G, Krall EA, et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990; 323: 878-883.
29. Reid I, Ames R, Evans M, et al. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women - a randomized controlled trial. Am J Med 1995; 98: 331-335.
30. Elders P, Netelenbos J, Lips P, et al. Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab 1991; 73: 533-540.
31. Chevalley T, Rizzoli R, Nydegger V, et al. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporos Int 1994; 4: 245-252.
32. Recker R, Hinders S, Davies K, et al. Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 1996; 11: 1961-1966.
33. Grant A, Avenell A, Campbell M, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium or vitamin D, RECORD). Lancet 2005; 365: 1621-1628.
34. Reid I, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women. Am J Med 2006; 119: 777-785.
35. Bischoff-Ferrari H, Dawson-Hughes B, Baron J, et al. Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomised controlled trials. Am J Clin Nutr 2007; 86: 1780-1790.
36. Chapuy MC, Arlot ME, Delmas PD, Meunier P. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994; 308: 1081-1082.
37. Dawson-Hughes B, Harris S, Krall E, Dallal G. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years or older. N Engl J Med 1997; 337: 670-676.
38. Larsen E, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004; 19: 370-378.
39. Peacock M, Liu G, McClintock R, et al. Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 2000; 85: 3011-3019.
40. Trivedi D, Doll R, Khaw K. Effect of four monthly oral vitamin D supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003; 326: 469-475.
41. Working Group of the Australian and New Zealand Bone and Mineral Society; Endocrine Society of Australia; Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005; 182: 281-285.
42. Osteoporosis Australia. Calcium, vitamin D and osteoporosis: a guide for GPs. 2nd ed. Sydney: CA, 2008. http://www.osteoporosis.org.au/files/ internal/oal_cacvitd_gp.pdf (accessed Feb 2009).
43. Guéguen L, Pointillart A. The bioavailability of dietary calcium. J Am Coll Nutr 2000; 19 (2 Suppl): 119S-136S.
44. Devine A, Dick I, Islam A, et al. Protein consumption is an important predictor of lower limb bone mass in elderly women. Am J Clin Nutr 2005; 81: 1423-1428.
45. Heaney RP. Protein intake and the calcium economy. J Am Diet Assoc 1993; 93: 1259-1260.
46. Specker B, Binkley T. Randomized trial of physical activity and calcium supplementation on bone mineral content in 3- to 5-year-old children. J Bone Miner Res 2003; 18: 885-892.
47. Iuliano-Burns S, Saxon L, Naughton G, et al. Regional specificity of exercise and calcium during skeletal growth in girls: a randomized controlled trial. J Bone Miner Res 2003; 18: 156-162.
48. Scopacasa F, Need AG, Horowitz M, et al. Effects of dose and timing of calcium supplementation on bone resorption in early menopausal women. Horm Metab Res 2002; 34: 44-47.
49. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996; 348: 1535-1541.
50. Liberman UA, Weiss SR, Bröll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 1995; 333: 1437-1443.
51. Harris S, Watts N, Genant H, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA 1999; 282: 1344-1352.
52. Ettinger B, Black D, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999; 282: 637-645.
53. Block G, Hulbert-Shearon T, Levin N, Port F. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617.
54. Reid I, Bolland M. Calcium supplementation and vascular disease. Climacteric 2008; 11: 280-286.